Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Francesco Maura, Eileen M. Boyle, David G. Coffey, Kylee Maclachlan, Dylan Gagler, Benjamin Diamond, Hussein Ghamlouch, Patrick Blaney, Bachisio Ziccheddu, Anthony Cirrincione, Monika Chojnacka, Yubao Wang, Ariel Siegel, James E. Hoffman, Dickran Kazandjian, Hani Hassoun, Emily Guzman, Sham Mailankody, Urvi A. Shah, Carlyn Tan, Malin Hultcrantz, Michael Scordo, Gunjan L. Shah, Heather Landau, David J. Chung, Sergio Giralt, Yanming Zhang, Arnaldo Arbini, Qi Gao, Mikhail Roshal, Ahmet Doǧan, Alexander M. Lesokhin, Faith E. Davies, Saad Z. Usmani, Neha Korde, Gareth J. Morgan, Ola Landgren
Topics & Concepts
ImmunotherapyMultiple myelomaMedicineImmune systemOncologyImmunologyInternal medicineMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsImmunotherapy and Immune Responses